After 5-year delay, CMC Pharmaceutical wins FDA nod for oral schizophrenia drug

CMG Pharmaceutical stumbled out of the gate—but five years and a pandemic later, the CHA Biotech affiliate has finally won U.S. FDA approval for Mezofy, a film-based version of the antipsychotic aripiprazole that dissolves on the tongue without water.

1 Like